Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2020 Dec 17;13(12):e236658. doi: 10.1136/bcr-2020-236658

Superior vena caval obstruction: a rare presentation of Behcet’s disease

Avinash Anil Nair 1,✉, D J Christopher 2, Fazil Moidu 3, Divya Chandran 3
PMCID: PMC7747549  PMID: 33334747

Abstract

A 25-year-old Indian man presented with low-grade fever followed by gradually increasing swelling of neck and face. Physical examination showed bilateral neck swelling, facial swelling and dilated veins in the upper chest. Superior vena cava (SVC) obstruction due to an underlying malignancy was suspected. CT thorax showed large saccular aneurysm with thrombosis of bilateral subclavian arteries of which the right one caused external compression of right innominate vein draining into the SVC. A history of recurrent oral and scrotal ulcers was obtained following which skin pathergy test was done, which was suggestive of a diagnosis of Behcet’s disease (BD). He responded to treatment with steroids and azathioprine. This report illustrates that rare nonmalignant cause such as BD could also present with SVC obstruction.

Keywords: connective tissue disease, vasculitis, respiratory medicine, lung cancer (oncology), interventional radiology

Background

Superior vena cava (SVC) obstruction is mostly caused by advanced malignancy (80%–90%),1 followed by indwelling catheters.2 SVC obstruction is considered as a medical emergency and is a poor prognostic sign when caused by malignancy.

We report the case of a young man who presented with features of SVC obstruction. He was evaluated with a clinical suspicion of anterior mediastinal tumour. However, a thrombosed vascular aneurysm was found to be compressing the right innominate vein draining into SVC, the cause of which was found to be Behcet’s disease (BD).

Case presentation

A 25-year-old man working as a mechanic presented with low-grade fever of 1-month duration and 2 weeks history of bilateral neck and facial swelling. He was treated at a local centre with antipyretics and two courses of antibiotics with no improvement in his condition. He was a non-smoker and non-alcoholic and gave no significant medical or surgical history.

On physical examination, his vitals were stable. He had diffuse facial swelling, bilateral neck swelling and supraclavicular fullness, and dilated veins in the upper chest. A clinical diagnosis of SVC obstruction was made. An anterior mediastinal tumour such as lymphoma was thought to be the most probable cause, considering his age and presentation. On detailed interrogation revealed history of oral and scrotal ulcers, for which he sought treatment with native medications.

Investigations

Routine blood counts (neutrophils—82% and lymphocytes—18%), peripheral smear and liver and renal functions were normal. Acute phase reactants: erythrocyte sedimentation rate (21 mm) and C reactive protein (12 mg/L) were mildly elevated. Blood and urine cultures were sterile. Chest X-ray showed bilateral upper mediastinal widening with elevated right hemidiaphragm (figure 1). The three-dimensional volume-rendered CT image revealed bilateral subclavian aneurysm and the right saccular aneurysm of the subclavian artery, which was thrombosed, causing external compression of ipsilateral innominate vein draining into the SVC (figure 2) and collateral veins were seen over the chest wall (figure 3). The right elevated hemidiaphragm was thought to be due to phrenic nerve compression by the aneurysm. There was also aneurysmal dilatation of abdominal aorta—both supra and infra renal regions (figure 4). A diagnosis of BD was considered and skin pathergy test was performed and it was positive.

Figure 1.

Figure 1

Chest X-ray showing bilateral upper mediastinal widening with elevated right hemidiaphragm.

Figure 2.

Figure 2

Three-dimensional volume-rendered image showing bilateral subclavian artery aneurysm. Right subclavian artery aneurysm (arrow) noted compressing the ipsilateral innominate vein.

Figure 3.

Figure 3

Contrast enhanced axial CT showing collaterals along the right upper chest wall (white arrows).

Figure 4.

Figure 4

Three-dimensional volume-rendered CT showing multiple supra and infra renal aortic saccular aneurysms (white arrows). Prominent left accessory renal vein (arrowhead) draining into the left common iliac vein, secondary to compression of the left main renal vein by aortic aneurysm (thick arrow) at the same level.

Differential diagnosis

Initial presentation in this young male with SVC obstruction prompted us to consider the following anterior mediastinal tumours: lymphoma, thymoma and germ cell tumours.

In view of vascular aneurysm and history of orogenital ulceration, BD came up for consideration and skin pathergy test was ordered, which turned out to be positive and clinched the diagnosis.

Treatment

Treatment with high-dose oral steroids (initiated at 1 mg per kg body weight for 3 months and then gradually tapered) and azathioprine (initiated 50 mg two times per day orally gradually increased to 100 mg two times per day) and along with anticoagulation was commenced.

Outcome and follow-up

The patient had symptomatic improvement with reduced swelling and breathlessness after treatment and remained in remission during the 1-year follow-up.

Discussion

SVC obstruction was originally described by William Hunter in 1757 in a patient with a large syphilitic aortic aneurysm compressing the SVC.3 The most common causes in literature are thoracic malignancies;4 hence, most of the patients present to oncologists and pulmonary physicians.

BD is a multisystem inflammatory disease characterised by recurrent oral and genital ulcers along with uveitis and vasculitis.5 6 The disease is more prevalent in the ‘ancient silk route’, with the first case reported at Turkey in 1937.

Subclavian aneurysm causing external compression of superior vena cava without evidence of thrombosis is exceedingly rare in BD.5

The aetiology of BD is not clearly understood,7 the most widely accepted hypothesis is that it is a profound inflammatory response triggered by an infectious agent in a genetically susceptible host.8 The hallmark of the disease is recurrent oral and genital ulcers, which heals with scar.8 There is no specific diagnostic test or criteria. The most widely used is the International Study Group criteria.7 The vascular manifestations in BD predict the morbidity and mortality,9 the prevalence of which varies from 7.7% to 12.8%.10 11 It affects blood vessels of varying sizes and the venous system is involved more commonly than arteries.6 12 In the venous system, thrombosis especially in deep veins in lower limbs is the most common manifestation,9 it can also involve the vena cava. Aneurysms and pseudo aneurysms are seen in the arterial system, which could result in the dreaded complication of rupture.11

The backbone of treatment is immunosuppression with steroids along with second line agents like azathioprine or mycophenolate, which cause significant regression of vascular lesions.11 13 Cyclophosphamide is also used in life-threatening vascular complications like pulmonary artery aneurysms.7 12 In recent years, there is increasing evidence for the role of biologicals14 in BD molecules like gevokizumab, anakinra, canakinumab, tocilizumab and rituximab14. These are not only used for mucocutaneous and ocular manifestations but have shown benefit in vascular lesions as well. The role of surgery is considered only in cases after acute inflammation has settled or in case of life-threatening aneurysms with impending rupture.9

Learning points.

  • Superior vena cava obstruction can be due to causes other than malignancy and indwelling catheters.

  • Behcet’s’ disease is a vasculitic disorder which is a rare cause of SVC obstruction, resulting from aneurysm of the subclavian artery casuing external compression.

  • SVC obstruction in Behcet’s disease is mostly caused by venous thrombosis

Footnotes

Twitter: @avinash444@hotmail.com

Contributors: AAN has substantial contributions to the conception and design of the work. DJC edited the draft of work and final approval of the version published. FM reported all the images and provided valuable insights into radiological diagnosis of this condition. DC has given significant contribution to literature search and manuscript preparation and editing.

Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Competing interests: None declared.

Patient consent for publication: Obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1.Cohen R, Mena D, Carbajal-Mendoza R, et al. Superior vena cava syndrome: a medical emergency? Int J Angiol 2008;17:43–6. 10.1055/s-0031-1278280 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Krayem HK, Bowles A, Hanbali A, et al. Mediastinal hematoma with SVC syndrome from a central venous catheter insertion: a case report. Chest 2003;124:314S. [Google Scholar]
  • 3.Danias PG, Pipilis AG. Superior vena cava syndrome. 2 Treasure Island, FL: StatPearls Publishing, 2020: 1757–2007. [Google Scholar]
  • 4.Wing SC, Ricketts WM, Banka RB, et al. A rare cause for superior vena cava obstruction. Case Rep Child Meml Hosp Chic 2012;2012:bcr2012006456 10.1136/bcr-2012-006456 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kilicarslan R, Burakgazi G, Aglamis S, et al. Superior vena cava syndrome caused by behcet’s disease. J Belg Soc Radiol 2013;96:232 10.5334/jbr-btr.297 [DOI] [PubMed] [Google Scholar]
  • 6.Malik AA, Halabi AM, Jamil G, et al. Rare manifestation of Behcet’s syndrome: insight from multimodality cardiovascular imaging. Case Rep 2012;2012:bcr2012007148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Marshall SE. Behçet's disease. Best Pract Res Clin Rheumatol 2004;18:291–311. 10.1016/j.berh.2004.02.008 [DOI] [PubMed] [Google Scholar]
  • 8.Rokutanda R, Kishimoto M, Okada M. Update on the diagnosis and management of Behçet's disease. Open Access Rheumatol 2015;7:1–8. 10.2147/OARRR.S46644 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Fei Y, Li X, Lin S, et al. Major vascular involvement in Behçet's disease: a retrospective study of 796 patients. Clin Rheumatol 2013;32:845–52. 10.1007/s10067-013-2205-7 [DOI] [PubMed] [Google Scholar]
  • 10.Zhang Z, Peng J, Hou X, et al. Clinical manifestations of Behcet’s disease in Chinese patients. APLAR J Rheumatol 2006;9:244–7. 10.1111/j.1479-8077.2006.00208.x [DOI] [Google Scholar]
  • 11.Ko GY, Byun JY, Choi BG, et al. The vascular manifestations of Behçet's disease: angiographic and CT findings. Br J Radiol 2000;73:1270. 10.1259/bjr.73.876.11205670 [DOI] [PubMed] [Google Scholar]
  • 12.Yazici H. Behçet's syndrome: where do we stand? Am J Med 2002;112:75–6. 10.1016/S0002-9343(01)01081-6 [DOI] [PubMed] [Google Scholar]
  • 13.Rotondo C, Lopalco G, Iannone F, et al. Mucocutaneous involvement in Behçet’s disease: how systemic treatment has changed in the last decades and future perspectives. Mediators Inflamm 2015;2015:1–10. 10.1155/2015/451675 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Caso F, Costa L, Rigante D, et al. Biological treatments in Behçet’s disease: beyond anti-TNF therapy. Mediators Inflamm 2014;2014:1–14. 10.1155/2014/107421 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES